Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, announces effective May 1, 2024, that the CADScor System CPT III 0716T code has been officially removed from the United Healthcare Medicare Advantage non-covered list. This important development marks the first step in removing barriers to widespread usage for patients covered by this plan.
"We are thrilled to announce that the CADScor System CPT III 0716T code has been removed from the non-covered list for United Healthcare Medicare Advantage," said Aamir Mahmood, President & CEO of Acarix. "This decision reflects a positive change in patient accessibility. By allowing payment for the test, United Healthcare Medicare Advantage is aligning with the healthcare industry's shift towards value-driven practices, emphasizing quality and efficiency. The CADScor System provides an accurate and non-invasive tool for risk stratification of coronary artery disease at the point of care, enabling clinicians to make decisions, leading to better outcomes and cost-effective care."
